| Brand Name | Visbiome, VSL#3 |
| Generic Name | Multi-strain (Lactobacillus, Bifidobacterium, Streptococcus thermophilus) |
| Drug Class | Bile Acid Sequestrant |
| Availability | OTC/Supplement |
| Manufacturer | ExeGi Pharma |
| Indications | IBD (UC, Crohn’s), IBS, pouchitis |
| Type | Capsule, Sachet |
| Doses | 450-900 billion CFU/day |
| Route | Oral |
| Side Effects | Bloating, gas, mild abdominal cramps |
| Interactions | Generally safe; minimal systemic interaction; enhances gut health |
| Overdose | Generally safe; gas or bloating. |
| Missed Dose | Skip or take anytime. Do not overdose. |
| Contraindications | Severe immunocompromised states |
| Alternatives | L. acidophilus, L. rhamnosus GG |
| Co-Pay Assistance Program | Available OTC |
| Patient Assistance Program | Not available |
Dr. Bharat Pothuri is a Board-Certified Gastroenterologist and Hepatologist. With extensive experience in digestive health, he specializes in advanced endoscopic procedures, chronic GI disorder management, and preventive care. Dr. Pothuri is dedicated to providing expert, patient-focused insights to help improve gut health and overall well-being.
Etrasimod is used to treat moderate to severe cases of ulcerative colitis and it is already being evaluated to treat other inflammatory conditions like Crohn and multiple sclerosis.
Etrasimod is a drug which interferes with the movement of the white blood cells by binding in the immune system receptors so as to reduce inflammation in the bowels and other localized structures.
The possible side effects include common upper respiratory infection, headache, diarrhea, and moderate increase in liver enzymes. Heart problems can also be regarded as serious side effects.
Etrasimod is still under consideration as far as its role in the treatment of multiple sclerosis with clinical activity within the first day indicating potential in reducing the disease activity is concerned.
Etrasimod is a tablet that is taken orally and that is usually taken in a single dose per day. Your health care provider will prescribe the dosage and frequency and rely on the condition of your health.
Etrasimod is also in a clinical trial form of an ideated Crohn’s disease remedy, and according to certain preliminary experiments, the drug will help control the inflammation of the alimentary tract.
Ensure that you do not take Etrasimod unless advised by the doctor. The effect of its use on pregnancy is not entirely established and thus should be employed when necessary.
Etrasimod is able to interact with other medications, especially the ones capable of affecting the immune system. Do not forget to report to your health care provider about any of the medications you take.
You forgot to take some dose of Etrasimod, take it at once you remember, however, unless it is near the following dose, and then not. Do not take two doses at once.
Etrasimod feels its action over several weeks, especially in the treatment of inflammatory diseases, such as ulcerative colitis.
Related Conditions |
Related Blogs |
|---|---|
